Aduhelm Ancillary Costs to Push Medicare Spending Even Higher
A new cost analysis taking into account spending on ancillary health services suggests that prior cost analyses underestimated the anticipated costs of aducanumab.
Stay updated with breaking news from Brain Bleeding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new cost analysis taking into account spending on ancillary health services suggests that prior cost analyses underestimated the anticipated costs of aducanumab.
Cannabis use was linked to significantly increased risk of delayed cerebral hemorrhage in patients with aneurysmal SAH, potentially due to vasospasm, new research suggests.
When considering the choice of oral anticoagulant in patients with atrial fibrillation, apixaban appears to be preferable to rivaroxaban, another new study suggests.
Patients who experience stroke -- hemorrhagic or otherwise -- have a "very high" risk of epilepsy one year later, new research shows.
Consider repeat head CT scans for trauma patients who are taking any anticoagulants or antiplatelet medications concurrently with aspirin, researchers say.